NIH director addresses clinical hold on AstraZeneca vaccine
The director of the National Institutes of Health recently addressed the reasons behind AstraZeneca’s clinical hold on its coronavirus vaccine. During a Senate hearing this week, Dr. Francis Collins confirmed one person experienced an adverse reaction during trials.